Topic

Articles

Brazil offers opportunities and challenges for global pharmaceutical companies.

Report from Brazil July 2013

Jill E. Sackman, PhD, is a senior consultant at Numerof & Associates, Inc. (NAI), St. Louis, MO, www.nai-consulting.com.

A unique demographic and payer mix make ASEAN an increasingly attractive region.

Report from Southeast Asia

Jane Wan is a freelance writer based in Singapore.

The Taiwanese government engages in regulatory science in a move to boost its pharmaceutical sector.

Report from Taiwan

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Report from Brazil May 2013

Latin America&apos;s diverse growing market seeks regulatory harmonization.

Report from Latin America

The outlook of the European biotech sector may not be as bleak as apparently believed despite the current economic climate, but compared with their US rivals, biotech companies are still struggling to attract investors and secure funding.

European Biotech Struggles to Thrive

The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.

Report from Thailand

Strengthening government control or striving for compliance with international standards?

Report from Russia

Sean Milmo is a freelance writer based in Essex, UK.

Discussions are underway as the pharmaceutical sector calls for greater consistency in the global monitoring of GMP compliance and quality testing of APIs and finished medicines.

Europe and the United States to Negotiate a Free-Trade Agreement

Brazil's major vaccine producer innovates with stem-cell research.

Global Perspectives